These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 2847064

  • 1. Restoration of immune response by levamisole in B-77 virus induced tumor-bearing rats.
    Kalafut F, Kusenda J, Novotná L, Klobusická M.
    Neoplasma; 1988; 35(4):369-78. PubMed ID: 2847064
    [Abstract] [Full Text] [Related]

  • 2. Restoration by levamisole of immune responses suppressed in tumor-bearing mice.
    Shiraishi M, Himeno K, Nomoto K.
    Cancer Immunol Immunother; 1983; 15(2):121-5. PubMed ID: 6553512
    [Abstract] [Full Text] [Related]

  • 3. Cytotoxic T-cell-mediated antitumor effect of levamisole against murine syngeneic fibrosarcoma.
    Gomi K, Morimoto M, Nomoto K.
    Cancer Res; 1982 Oct; 42(10):4197-202. PubMed ID: 6980702
    [Abstract] [Full Text] [Related]

  • 4. [Augmentation of antitumor immune responses by the antitumor antibiotic bleomycin].
    Hosokawa M, Morikawa K.
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2700-8. PubMed ID: 6210061
    [Abstract] [Full Text] [Related]

  • 5. Increased sensitivity of murine leukemia virus-infected tumor cells to lymphocyte-mediated cytotoxicity.
    Kasai M, Yamaguchi H, Hosokawa M, Mizushima Y, Kobayashi H.
    J Natl Cancer Inst; 1981 Aug; 67(2):417-22. PubMed ID: 6267345
    [Abstract] [Full Text] [Related]

  • 6. Influence of surgical removal and effect of levamisole on cytotoxic T-cell-mediated antitumor immunity in mice.
    Gomi K, Morimoto M, Nomoto K.
    Cancer Res; 1983 Nov; 43(11):5120-5. PubMed ID: 6604572
    [Abstract] [Full Text] [Related]

  • 7. Characterization of immunosuppressor cells in rats immunized with solubilized tumor-associated antigens prepared from a methylcholanthrene-induced fibrosarcoma.
    Minami A, Kasai M, Mizushima Y, Takeichi N, Hosokawa M, Kobayashi H.
    Cancer Res; 1980 Jul; 40(7):2129-34. PubMed ID: 6446378
    [Abstract] [Full Text] [Related]

  • 8. Recombinant tumor necrosis factor alpha inhibits growth of methylcholanthrene-induced sarcoma and enhances natural killer activity of tumor-infiltrating lymphocytes in aging rats.
    Ziółkowska M, Nowak JJ, Janiak M, Ryzewska A.
    Arch Immunol Ther Exp (Warsz); 1993 Jul; 41(5-6):357-64. PubMed ID: 8010877
    [Abstract] [Full Text] [Related]

  • 9. Effect of Nocardia rubra cell wall skeleton on T-cell-mediated cytotoxicity in mice bearing syngeneic sarcoma.
    Kawase I, Uemiya M, Yoshimoto T, Ogura T, Hirao F, Yamamura Y.
    Cancer Res; 1981 Feb; 41(2):660-6. PubMed ID: 6969630
    [Abstract] [Full Text] [Related]

  • 10. [Effects of levamisole on methylcholanthrene-induced tumor. I. Its antitumor effect and immunological mechanism].
    Gomi K, Morimoto M, Nomoto K.
    Gan To Kagaku Ryoho; 1982 Jul; 9(7):1262-8. PubMed ID: 7184454
    [Abstract] [Full Text] [Related]

  • 11. Effect of cyclophosphamide on mice bearing methylcholanthrene-induced fibrosarcomas.
    Yu S, Lannin DR, Tsui-Collins AL, McKhann CF.
    Cancer Res; 1980 Aug; 40(8 Pt 1):2756-61. PubMed ID: 7388826
    [Abstract] [Full Text] [Related]

  • 12. [The immunobiological properties of trimezon and levamisole on models of humoral and cell-mediated immunogenesis].
    Liubin GS, Kuz'mitskiĭ BB.
    Eksp Klin Farmakol; 1997 Aug; 60(1):50-2. PubMed ID: 9162286
    [Abstract] [Full Text] [Related]

  • 13. [Poliovirus-induced immunosuppression in mice and the possibilities for its correction].
    Shirobokov VP, Giulling EV, Korniushenko ON, Negrebetskaia EN, Rozenfel'd OL.
    Mikrobiol Zh (1978); 1986 Aug; 48(1):86-90. PubMed ID: 2855844
    [No Abstract] [Full Text] [Related]

  • 14. Anti-tumor activity of recombinant tumor necrosis factor on mouse fibrosarcoma in vivo and in vitro.
    Tomazic VJ, Farha M, Loftus A, Elias EG.
    J Immunol; 1988 Jun 01; 140(11):4056-61. PubMed ID: 3372997
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A, Nowicky JW.
    Drugs Exp Clin Res; 1996 Jun 01; 22(3-5):103-13. PubMed ID: 8899312
    [Abstract] [Full Text] [Related]

  • 17. Adoptive transfer of immunity against solid fibrosarcoma in mice with splenocytes and peritoneal exudate cells obtained after in vitro sensitization and in vivo immunization with cis-dichlorodiamine platinum(II) treated fibrosarcoma cells.
    Sodhi A, Tandon P, Sarna S.
    Arch Geschwulstforsch; 1985 Jun 01; 55(1):47-61. PubMed ID: 3872651
    [Abstract] [Full Text] [Related]

  • 18. Macrophage tumoricidal activity as a possible antitumor mechanism associated with the local injection of allogeneic spleen cells into rats.
    Kawase I, Komuta K, Namba M, Yokota S, Ogura T, Kishimoto S.
    Cancer Res; 1986 Mar 01; 46(3):1047-54. PubMed ID: 3510719
    [Abstract] [Full Text] [Related]

  • 19. Specific induction of local antitumor effector cells mediated in vivo by the circulating lymphocyte pool.
    Crum ED.
    Cancer Res; 1987 Nov 01; 47(21):5584-9. PubMed ID: 3311355
    [Abstract] [Full Text] [Related]

  • 20. Study of destructive mechanisms of the immune response to sarcoma I allograft in mice.
    Vidrnová M, Nouza K, Nĕmec M.
    Neoplasma; 1984 Nov 01; 31(4):369-80. PubMed ID: 6472512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.